Výsledky vyhledávání - "Wendy P. Battisti"

Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3

Autor: LaVerne A. Mooney, Dan Bridges, Karen L. Woolley, Angela Cairns, Wendy P Battisti, James A Gurr, Elizabeth Wager, Carol Sanes-Miller, Teresa Peña, B. Jane Moore, Keith Veitch, Yvonne E Yarker, Leslie Citrome, Lise Baltzer, Christopher I. Carswell

Publikováno v: Annals of Internal Medicine. 163:461-464

This updated Good Publication Practice (GPP) guideline, known as GPP3, builds on earlier versions and provides recommendations for individuals and organizations that contribute to the publication of research results sponsored or supported by pharmace

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b339f6912c0e3bc7e6e294a674e8522
https://doi.org/10.7326/m15-0288

Zobrazit plný text záznamu

Use of Adjectives in Abstracts when Reporting Results of Randomized, Controlled Trials from Industry and Academia

Autor: Jesse A. Berlin, Susan Glasser, Martijn J. Schuemie, M. Soledad Cepeda, Wendy P. Battisti

Publikováno v: Drugs in R&D

Objective Accurate representation of study findings is crucial to preserve public trust. The language used to describe results could affect perceptions of the efficacy or safety of interventions. We sought to compare the adjectives used in clinical t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9c328956a61583c3f7246072d9b03ab
http://europepmc.org/articles/PMC4359185

Zobrazit plný text záznamu

Topiramate for Migraine Prevention in Adolescents: A Pooled Analysis of Efficacy and Safety

Autor: Wendy P. Battisti, Astrid Gendolla, Eric C. Yuen, Paul Winner, Steven Wang, Jeffrey S. Nye, Catherine Stayer

Publikováno v: Headache: The Journal of Head and Face Pain. 46:1503-1510

Objective.—To characterize the efficacy and safety of topiramate for migraine prevention in adolescents from 3 randomized, 26-week, double-blind, placebo-controlled trials. Background.—Limited information is available regarding the efficacy and s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::708385a2c4efebba45fde4dd2b81a41f
https://doi.org/10.1111/j.1526-4610.2006.00610.x

Zobrazit plný text záznamu

The effect of simvastatin on triglyceride-rich lipoproteins in patients with type 2 diabetic dyslipidemia: a SILHOUETTE Trial Sub-study

Autor: Adrian S. Dobs, Joanne Palmisano, Michael Miller, Wendy P. Battisti, Zhong Yuan

Publikováno v: Current Medical Research and Opinion. 22:343-350

To determine if simvastatin effectively decreases the elevated levels of triglyceride (TG), TG-rich lipoproteins, and small, dense LDL particles, which are characteristic of diabetic dyslipidemia.We conducted a prespecified analysis from a double-bli

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f8ebe6d067aee072b0cd2dcdbc53db5
https://doi.org/10.1185/030079906x80521

Zobrazit plný text záznamu

Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: Subanalyses of data from a randomized, double-blind, placebo-controlled trial

Autor: Joanne Palmisano, Margo A. Denke, Wendy P. Battisti, William E. Brady, Thomas A. Pearson, Patrick E. McBride

Publikováno v: The American Journal of Geriatric Pharmacotherapy. 3:218-228

Background: The Ezetimibe Add-on to Statin for Effectiveness (EASE) trial examined the effectiveness and safetyprofile of ezetimibe (EZE) added to ongoing statin therapy in 3030 patients with low-density lipoprotein cholesterol (LDL-C) levels exceedi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::22c379a167fdfc10bbf7c9260b0163c2
https://doi.org/10.1016/j.amjopharm.2005.12.009

Zobrazit plný text záznamu

Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)

Autor: Joanne Palmisano, Zhong Yuan, Gloria Lena Vega, William E. Brady, Wendy P. Battisti, Scott M. Grundy

Publikováno v: The American Journal of Cardiology. 95:462-468

Patients with combined hyperlipidemia (elevated triglyceride [TG] levels, elevated low-density lipoprotein [LDL] cholesterol, and multiple lipoprotein abnormalities) are at increased risk for coronary heart disease. We conducted a multicenter (in the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ae69393268bdc1a5840d5850cf14bf5
https://doi.org/10.1016/j.amjcard.2004.10.012

Zobrazit plný text záznamu

Pain management in osteoarthritis: A focus on onset of efficacy—a comparison of rofecoxib, celecoxib, acetaminophen, and nabumetone across four clinical trials

Autor: Arthur L. Weaver, Gregory P. Geba, Nathaniel P. Katz, Wendy P. Battisti, Adam B. Polis, Alan J. Kivitz, Alan K. Matsumoto

Publikováno v: The Journal of Pain. 5:511-520

We compared onset of efficacy (during days 1 to 6) of 2 coxibs (rofecoxib, celecoxib) with acetaminophen and nabumetone by using a prespecified approach to data from 4 similarly designed 6-week randomized osteoarthritis trials. In 2 trials, rofecoxib

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::820da2b216115a546836432299c3901c
https://doi.org/10.1016/j.jpain.2004.09.004

Zobrazit plný text záznamu

A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended-release tablets on sleep architecture in patients with schizophrenia

Autor: Remy Luthringer, Mariëlle Eerdekens, Muriel Muzet, Luc Staner, Nadine Noel, K Talluri, Joseph Palumbo, Adriaan Cleton, Cristiana Gassmann-Mayer, Wendy P. Battisti

Publikováno v: International clinical psychopharmacology. 22(5)

The effects of paliperidone extended-release on sleep architecture in patients with schizophrenia-related insomnia were evaluated in this multicenter, double-blind, randomized, placebo-controlled study. Patients received paliperidone extended-release

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cade3c9d317fec5eb37736026fb3821
https://pubmed.ncbi.nlm.nih.gov/17690599

Zobrazit plný text záznamu

Effectiveness of ezetimibe added to ongoing statin therapy in modifying lipid profiles and low-density lipoprotein cholesterol goal attainment in patients of different races and ethnicities: a substudy of the Ezetimibe add-on to statin for effectiveness trial

Autor: Patrick E. McBride, Thomas A. Pearson, Joanne Palmisano, Margo A. Denke, William E. Brady, Russell A. Gazzara, Wendy P. Battisti

Publikováno v: Mayo Clinic proceedings. 81(9)

To examine whether the improvements in lipid profiles and low-density lipoprotein cholesterol (LDL-C) goal attainment found in the Ezetimibe Add-On to Statin for Effectiveness trial occurred equally in the black, Hispanic, and white patient populatio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a5ab5bb2446b67122ed54ef24153222
https://pubmed.ncbi.nlm.nih.gov/16970214

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání